The Dominican Society of Medical Oncology has expressed reservations about the selection of 13 expensive drugs announced by the National Social Security Council. Its president emphasized that effective treatments for breast cancer and other conditions have been omitted. He also denounced the lack of consultation with specialists and called for a reevaluation of the choice of drugs to better meet the needs of patients.